Toggle navigation
Home
Search
Services
Blog
Contact
About
Oral Buprenorphine Nanoparticle
Nanotherapeutics, Inc., Alachua, FL, United States
Search grants from Nanotherapeutics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Environmental chemicals promote adipogenesis by targeting THY1
Phase 2 Trial of Gamunex ( Intravenous Gammaglobulin) for Sickle Cell Acute Pain
Role of Cyclophilin D in Abeta- induced synaptic injury
University of Rochester - Ccop Research Base
Cognitive and cortical restructuring in the acquisition of negative number concepts.
Recently added grants:
Optical control of T cell metabolism
The benefits and harms of lung cancer screening in Florida
Synthesis and in vitro and in vivo screening of fused and tethered heterocyclic peptidomimetics for the discovery of new analgesics with decreased side effects
JAK/STAT signaling in the pathogenesis of DNMT3A mutant T-ALL
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44DA57741-5-0-1
Application #
7706650
Study Section
Project Start
2005-09-15
Project End
2008-09-30
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$116,660
Indirect Cost
Institution
Name
Nanotherapeutics, Inc.
Department
Type
DUNS #
073438462
City
Alachua
State
FL
Country
United States
Zip Code
32615
Comments
Be the first to comment on this grant